Open-label, Randomized, Multicenter, Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan), Manufactured by Boryung Pharmaceutical Co., Ltd, Republic of Korea, Tablets 60/120 mg and Cozaar® (Losartan), Manufactured by MERCK SHARP & DOHME B.V., Netherlands, Tablet 50/100 mg in Adult Patients With Grade I-II Arterial Hypertension
Phase of Trial: Phase III
Latest Information Update: 08 May 2019
Price : $35 *
At a glance
- Drugs Fimasartan (Primary) ; Losartan
- Indications Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors R-Pharm
- 09 Feb 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 05 Apr 2015 Planned primary completion date changed from 1 Jan 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 05 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.